Newer glucose-lowering drugs and risk of dementia: A meta-analysis of cardiovascular outcome trials

J Am Geriatr Soc. 2022 Sep;70(9):2719-2722. doi: 10.1111/jgs.17895. Epub 2022 May 25.

Huilin Tang¹, Shu Niu¹, Joshua Brown^{1

2}, Jingkai Wei³, Hui Shao^{1

2}, Jiang Bian⁴, Jingchuan Guo^{1

2}

¹ Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
² Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.
³ Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
⁴ Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.

No abstract available

Publication types